Stock RSLS RESHAPE LIFESCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Delayed Nasdaq
Other stock markets
 03:41:30 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.1712 USD -3.82% Intraday chart for ReShape Lifesciences Inc. +3.57% -31.44%
Apr. 12 North American Morning Briefing : Big Banks Kick -2- DJ
Apr. 01 Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024

Evolution of the average Target Price on ReShape Lifesciences Inc.

Price target over the last 5 years

History of analyst recommendation changes

55056965198dc02ef7.MVjVruFThwOwGNdvqbYILeKCmMvsxKsRA8BaRvXUur0.c2yW3bIp5EvvSZor7YFRGoW34b3clOV4XIsjNZ-Ql-gFaLH_livLb4Vang~ad5eb67ff62ae54f3df03e5e859f96d4

Analyst Recommendations on ReShape Lifesciences Inc.

Maxim Group Adjusts ReShape Lifesciences Price Target to $1.50 From $3, Maintains Buy Rating MT
Alliance Global Adjusts Price Target on ReShape Lifesciences to $4.65 From $5.50, Reiterates Buy Rating MT
Maxim Lowers Price Target for ReShape Lifesciences to $4 From $8, Maintains Buy Rating MT
Alliance Global Adjusts Price Target on ReShape Lifesciences to $5.50 From $10.25, Reiterates Buy Rating MT
RESHAPE LIFESCIENCES : Maxim Group Initiates Coverage on ReShape Lifesciences With Buy Rating, $8 Price Target MT
RESHAPE LIFESCIENCES : Alliance Global Partners Adjusts ReShape Lifesciences PT to $13.75 From $18.50, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.178 USD
Average target price
1 USD
Spread / Average Target
+461.80%
High Price Target
1 USD
Spread / Highest target
+461.80%
Low Price Target
1 USD
Spread / Lowest Target
+461.80%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ReShape Lifesciences Inc.

Maxim
Alliance Global Partners

Ratings for ReShape Lifesciences Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. Consensus ReShape Lifesciences Inc.